Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer.
Saved in:
| Title: | Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer. |
|---|---|
| Authors: | Ríos-Hoyo A; Yale Cancer Center, Yale School of Medicine, New Haven, CT., Cobain E; University of Michigan, Ann Arbor, MI., Huppert LA; University of California San Francisco Comprehensive Cancer Center, San Francisco, CA., Beitsch PD; Dallas Surgical Group, Dallas, TX., Buchholz TA; Scripps Health, Scripps Clinic Medical Group, San Diego, CA., Esserman L; University of California San Francisco Comprehensive Cancer Center, San Francisco, CA., van 't Veer LJ; University of California San Francisco Comprehensive Cancer Center, San Francisco, CA., Rugo HS; University of California San Francisco Comprehensive Cancer Center, San Francisco, CA., Pusztai L; Yale Cancer Center, Yale School of Medicine, New Haven, CT. |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 01; Vol. 42 (22), pp. 2632-2636. Date of Electronic Publication: 2024 Apr 09. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1527-7755 |
|---|---|
| DOI: | 10.1200/JCO.23.02614 |
